Camlin Fine Sciences (CAMLINFINE) Q1 25/26 earnings summary

Executive summary

• Q1 FY2026 revenue was INR 423 crores (Rs. 4,236 mn), down from INR 437 crores (Rs. 4,375 mn) year-over-year, mainly due to annual maintenance shutdowns and sluggish demand in Specialty Ingredients Straights impacting production and margins.

• EBITDA for the quarter was INR 19 crores (Rs. 190 mn), with a margin of 4.5%, affected by one-time costs and lower output.

• Blends business showed strong growth across geographies and resilience in key markets, while Vanillin remained stable despite channel stock and tariff uncertainties.

• Losses from discontinued operations were curtailed, and the company continues to focus on high-value blends and additives.

• Board approved unaudited financial results for Q1 FY26 and key board and management changes were announced.

Financial highlights

• Revenue declined by INR 14 crores year-over-year due to plant shutdowns and lower throughput.

• Q1FY26 EBITDA was Rs. 190 mn, with an EBITDA margin of 4.5%, down from 13.6% in Q4FY25.

• One-time costs included INR 12.5 crores in unabsorbed fixed costs and INR 7.5 crores in employee performance bonuses.

• PAT from continuing operations was a loss of Rs. 42.5 mn, with a PAT margin of -1.0%.

• Gross margin is currently at 44%, expected to remain in the 40%-45% range.

Outlook and guidance

• Vanillin business expected to operate at 2,500-3,000 tons annually, with average realizations of $13-$14 per kg.

• Blends business growth target of 20% remains intact.

• Channel inventory in key markets expected to clear in 3-4 months, with ramp-up benefits anticipated from Q3 FY2026.

• FY26 will see commercialization of new specialty ingredients, with a strategic focus on high-value blends and downstream products.

• Capacity utilization for vanillin projected to reach 70%-80% in FY2027 and full utilization by FY2028.